Mean percent changes in lipid values in 203 type 2 diabetic patients on placebo and 3 different doses of pramlintide for 4 weeks

Derived from .<p><b>Copyright information:</b></p><p>Taken from "Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk"</p><p></p><p>Vascular Health and Risk Management 2008;4(2):355-362.</p><p>Published online Jan 2008</p><p>PMCID:PMC2496974.</p><p>© 2008 Dove Medical Press Limited. All rights reserved